Vesiculture 30 mg Freeze-dried powder for reconstitution
PDF Leaflet Revision Date: 08 June 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Immunoprophylaxis and immunotherapy for superficial bladder cancer.
Dosage (summary)
120 mg (4 vials) for intravesical use, 6 installations at weekly intervals.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Antibiotics
- Immunosuppressants
- Anti-tuberculosis medicines
Contraindications
- Hypersensitivity to BCG
- Active tuberculosis
- Reduced immune response
- Pregnancy
- Breastfeeding
Common side effects
- Cystitis
- Pollakiuria
- Fever
- General malaise
Counselling Points
- Avoid contact with immunocompromised individuals
- Postpone treatment if urinary tract infection is present
- Use condoms for one week post-treatment
Serious warnings
- Risk of systemic BCG infection
- Monitor for urinary tract infection
- Traumatic catheterization risks
Important Disclaimer
The Vesiculture 30 mg Freeze-dried powder for reconstitution professional information leaflet below is the property of Kahma Biotech and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
